CClinicalTrials.gg
CompletedNCT04143308Updated Jun 21, 2024

The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia

An interventional study of Simultaneous training of walking and cognitive group and Cognitive training group in Schizophrenia, Cognitive Function and Physical Activity, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-06-21.

Sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

The object is to develop a training system of simultaneous walking and cognitive training for improving cognitive function of people with schizophrenia. The training program, called "Simultaneous Walk And Think for Cognitive Health mobile application software"(SWATCH App), is developed by researchers. A randomized controlled trial will be carried out to test the effectiveness of the training system. Ninety participants will be randomly assigned to: simultaneous training of walking and cognitive group, the cognitive training group, and treatment as usual group. The intervention for those groups will lasts for 12 weeks, with a 12 week of followup. The measurements include the cognitive function, physical fitness, and quality of life.

Read the detailed description

Background: Schizophrenia is one of the severe mental disorders. In addition to psychiatric symptoms, cognitive impairment is a key clinical feature in this population, which significantly negatively influences their functional performance and independence. While the cognitive remediation therapy demonstrates positive results, it often involves specialized and expensive computerized cognitive training system, which limits its application in clinical setting. More evidence is available to support the benefits of exercise training on cognitive functions of schizophrenia. Combination of exercise and cognitive training is a promising program and can improve cognitive functions of the elderly. However, this combined therapy is still limited to schizophrenia. Simultaneous training of walking and cognitive tasks via auditory mobile application is an innovative program for saving cost, time, and manpower. Further study is needed to develop the simultaneous training program and to examine the effectiveness.

Purposes: To examine the effects of the training program on cognitive functions, fitness, functional performance and quality of life.

Methods: A 3-arm, single-blinded, randomized controlled trial is used to recruit 90 participants and then randomly allocated to the simultaneous training group, the cognitive training group, and the treatment as usual group. The first two training groups receive training for 30-40 minutes, 3 times a week for 12 weeks, as well as a follow-up of 12 weeks. All participants will be assessed at baseline, post-test and follow-up assessment. Primary outcome is cognitive function and secondary outcomes are fitness, functional performance, and quality of life.

Contribution: The study can be used as an evidence-based program to improve cognitive functioning of people with schizophrenia. With the development of mobile App and the use of fitness wearable device, the training program enables people with schizophrenia to walk and practice cognitive training simultaneously in a group format. It will help clinical professionals be able to serve the increasing number of people with severe mental illness with less manpower and specialized equipment. The study is also helpful to better understanding the isolated role of aerobic exercise in the dual-task training, and to apply to other groups, like the elderly or dementia.

02

Conditions studied

  • Schizophrenia
  • Cognitive Function
  • Physical Activity
  • Quality of Life

Browse trials for

Keywords

  • Schizophrenia
  • Cognitive functional training
  • Dual-task training
  • Aerobic exercise
  • Mobile application
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 90 is above the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital is the lead sponsor of 281 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Diagnosis of schizophrenia or schizoaffective disorder by a psychiatric clinician on the basis of the criteria set the Diagnostic and Statistical Manual of Mental Disorders 5th edition, DSM-5, has been more than 1 year.
  2. Age 20-60 years old.
  3. Living in daycare center or community-based mental health rehabilitation services or rehabilitation ward.
  4. Having stable psychiatric conditions (i.e., primary psychiatric medications had not changed for more than two months)
  5. The MATRICS Consensus Cognitive Battery (MCCB) (Nuechterlein et al., 2008) shows that at least one domain with cognitive impairment (below the value of -1SD).
  6. Can follow the research process and sign the consent form.

Exclusion criteria

Exclusion Criteria:

  1. Traumatic brain injury and other neurological diseases, alcohol and substance abuse
  2. Pregnancy, cardiovascular disease, and unsuitable to exercise training due to physical movement difficulties
  3. According participants' self-report, having following conditions, including severe heart failure, myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, COPD, poor glycemic control (i.e., dialysis, diabetic neuropathy or retinopathy) and lower extremity arthritis
  4. Uncontrolled hypertension with SBP> 160 mmHg or DBP> 110 mmHg
  5. Diagnosis of intellectual disability
  6. Unconscious or confusion of consciousness
  7. Participating in other intervention studies
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Simultaneous training of walking and cognitive group

    1. Wearable technology (fitness wristband \& App) 2. SWATCH system (App \& controller) 3. 3 times a week (30 mins/ each time) 4. Lasts for 12 weeks 5. Simultaneous walking and cognitive training

    Other: Simultaneous training of walking and cognitive group

  • Active comparator
    Cognitive training group

    1. Wearable technology (fitness wristband \& App) 2. SWATCH system (App) 3. 3 times a week (30 mins/ each time) 4. Lasts for 12 weeks 5. Cognitive training while sitting

    Other: Cognitive training group

  • Active comparator
    Treatment as usual group

    1. Keep treatment as usual group at health care system.

    Other: Treatment as usual group

Interventions

  • OtherSimultaneous training of walking and cognitive group

    Device: 1. SWATCH system (App \& controller) 2. Wearable technology Fitness wristband \& APP

  • OtherCognitive training group

    Device: 1. SWATCH system (App) 2. Wearable technology Fitness wristband \& APP

  • OtherTreatment as usual group

    Keep treatment as usual

06

What researchers measure

Primary outcomes

  1. Cognitive function

    MATRICS Consensus Cognitive Battery: Traditional Chinese Version (MCCB) consists of 10 individually administered tests to measure cognitive performance in the following seven domains: 1. Processing Speed 1.1 Trail Making Test (TMT). 1.2 Brief Assessment of Cognition in Schizophrenia: Symbol Coding (BACS SC). 1.3 Category Fluency: Animal Naming (Fluency). 2. Attention 2.1 Continuous Performance Test: Identical Pairs (CPT-IP). 3. Working memory 3.1 Wechsler Memory Scale-III (WMS III): Spatial Span. 3.2 Wechsler Letter: Number Sequencing (WAIS-III). 4. Verbal Learning 4.1 Hopkins Verbal Learning Test-Revised (HVLT-R). 5. Visual Learning 5.1 Brief Visuospatial Memory Test-Revised (BVMT-R). 6. Reasoning and Problem Solving 6.1 Neuropsychological Assessment Battery (NAB): Mazes. 7. Social Cognition 7.1 Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT): Managing Emotions.

    Time frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

Secondary outcomes

  1. Body composition

    Using Body Mass Index (BMI) as the measurement of body composition, which weight and height will be combined to report BMI in kg/m\^2.

    Time frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

  2. Cardiorespiratory fitness

    Using 6-minute walk test (6MWT) as the measurement, which let the participant walks as far as possible over a total of six minutes on hard and flat floor. And the researcher will measure the distance that participant walks in 6 minutes.

    Time frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

  3. Leg muscular strength and endurance

    Using 30-Second Sit to Stand Test. The participant will sit in the middle of the chair, and rise to a full standing position, then sit back down again. Repeat these movements for 30 seconds. And researcher will count the times.

    Time frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

  4. Balance and Agility

    The Timed Up and Go test (TUG). It measures the time that the participant takes to rise from a chair, walk eight foots, turn around, walk back to the chair, and sit down.

    Time frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

  5. Dual-Task Performance Involving Hand Dexterity and Cognitive Tasks

    Dual-Task Performance Involving Hand Dexterity and Cognitive Tasks, this test is combine the Purdue Pegboard Test (PPT; Tiffin \& Asher, 1948) and the Serial Sevens Subtraction Test (SSST; Manning, 1982), Purdue Pegboard Test use to measures hand dexterity; Serial Sevens Subtraction Test as a cognitive task for the dual-task condition.

    Time frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

  6. Instrumental Activity of Daily Living (IADL)

    Lawton and Brody Instrumental Activity of Daily Living Scale is a self-report survey. It is used to evaluate the degree of participant's instrumental activities. There are total 8 descriptions, the scale scores ranges is between 0 to 8. The higher values represent a better outcome.

    Time frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

  7. Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4)

    Schizophrenia Quality of Life Scale Revision 4 is a self-report survey. It is used to evaluate the degree of participant's quality of life. There are total 33 items, the scale scores statements are rated 1 (never) to 5 (always). The higher values represent a better outcome.

    Time frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test)

07

Study locations

1 site
  • Ming-De Chen
    Kaohsiung, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04143308
Lead sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Responsible party
Sponsor
First posted
Oct 29, 2019
Start date
Nov 5, 2019
Primary completion
Jul 7, 2021
Completion
Jul 7, 2021
Last update
Jun 21, 2024

Study contacts

Ming-De Chen, Ph.D.
principal investigator · Department of Occupational Therapy, College of Health Sciences, Kaohsiung Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion